| Mahnomen Health Center | |
| 414 W Jefferson Po Box 396, Mahnomen, Minnesota 56557 | |
| (218) 935-2511 | |
| Not Available |
| Name | Mahnomen Health Center |
|---|---|
| Type | Critical Access Hospital |
| Location | 414 W Jefferson Po Box 396, Mahnomen, Minnesota |
| Ownership | Government - Local |
| Emergency Services | Yes |
| Medicare ID (CCN) | 241300 |
| NPI Number | 1942233234 |
| Organization Name | MAHNOMEN HEALTH CENTER |
| Address | 414 W Jefferson Ave, Mahnomen, MN 56557 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 218-935-2511 |
News Archive
Nigerian "President Goodluck Jonathan and the Prime Minister of Norway, Jens Stoltenberg, have said this year will be 'a tipping point for change' and global awareness for saving more lives, especially those of women and children."
Recent disease events such as SARS, H1N1 and avian influenza, and haemorrhagic fevers have focussed policy and public concern as never before on epidemics and so-called 'emerging infectious diseases'. Understanding and responding to these often unpredictable events have become major challenges for local, national and international bodies.
Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.
Noting "April 25 marks World Malaria Day, an opportunity for those who work to defeat the illness to review progress and renew commitments," Laurence Slutsker and Patrick Kachur of the CDC's Division of Parasitic Diseases and Malaria, write in a Malaria Journal opinion piece, "After a decade of steady success, this year's commemoration of the date is also an opportunity to reconsider current approaches and assess the state of the science needed to keep pace in the global effort to combat malaria."
People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday's Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
› Verified 3 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Nigerian "President Goodluck Jonathan and the Prime Minister of Norway, Jens Stoltenberg, have said this year will be 'a tipping point for change' and global awareness for saving more lives, especially those of women and children."
Recent disease events such as SARS, H1N1 and avian influenza, and haemorrhagic fevers have focussed policy and public concern as never before on epidemics and so-called 'emerging infectious diseases'. Understanding and responding to these often unpredictable events have become major challenges for local, national and international bodies.
Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.
Noting "April 25 marks World Malaria Day, an opportunity for those who work to defeat the illness to review progress and renew commitments," Laurence Slutsker and Patrick Kachur of the CDC's Division of Parasitic Diseases and Malaria, write in a Malaria Journal opinion piece, "After a decade of steady success, this year's commemoration of the date is also an opportunity to reconsider current approaches and assess the state of the science needed to keep pace in the global effort to combat malaria."
People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday's Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
› Verified 3 days ago
Mahnomen Health Center Critical Access Hospital Location: 414 W Jefferson Po Box 396, Mahnomen, Minnesota 56557 Phone: (218) 935-2511 |